v3.25.2
CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   34,211,190      
Beginning balance at Dec. 31, 2023 $ 196,988 $ 5 $ 441,641 $ (2) $ (244,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (35,731)       (35,731)
Recognition of stock-based compensation expense 5,519   5,519    
Issuance of common stock, net of issuance costs (in shares)   3,281,250      
Issuance of common stock, net of issuance costs 98,329 $ 1 98,328    
Issuance of pre-funded warrants, net of issuance costs 9,365   9,365    
Exercise of vested stock options (in shares)   49,310      
Exercise of vested stock options 802   802    
Issuance of common stock upon the vesting of restricted stock units (in shares)   207,718      
Other comprehensive income (loss) (61)     (61)  
Ending balance (in shares) at Mar. 31, 2024   37,749,468      
Ending balance at Mar. 31, 2024 275,211 $ 6 555,655 (63) (280,387)
Beginning balance (in shares) at Dec. 31, 2023   34,211,190      
Beginning balance at Dec. 31, 2023 196,988 $ 5 441,641 (2) (244,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (69,021)        
Ending balance (in shares) at Jun. 30, 2024   38,030,385      
Ending balance at Jun. 30, 2024 252,246 $ 6 566,093 (176) (313,677)
Beginning balance (in shares) at Mar. 31, 2024   37,749,468      
Beginning balance at Mar. 31, 2024 275,211 $ 6 555,655 (63) (280,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (33,290)       (33,290)
Recognition of stock-based compensation expense 7,481   7,481    
Issuance of common stock, net of issuance costs 3   3    
Exercise of vested stock options (in shares)   99,678      
Exercise of vested stock options 1,818   1,818    
Issuance of common stock upon the vesting of restricted stock units (in shares)   115,251      
Shares issued in connection with the employee stock purchase plan (in shares)   65,988      
Shares issued in connection with the employee stock purchase plan 1,136   1,136    
Other comprehensive income (loss) (113)     (113)  
Ending balance (in shares) at Jun. 30, 2024   38,030,385      
Ending balance at Jun. 30, 2024 $ 252,246 $ 6 566,093 (176) (313,677)
Beginning balance (in shares) at Dec. 31, 2024 38,349,826 38,349,826      
Beginning balance at Dec. 31, 2024 $ 224,534 $ 6 584,559 179 (360,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (25,120)       (25,120)
Recognition of stock-based compensation expense 6,930   6,930    
Issuance of common stock, net of issuance costs (in shares)   3,230,336      
Issuance of common stock, net of issuance costs 134,771   134,771    
Exercise of vested stock options (in shares)   78,436      
Exercise of vested stock options 1,437   1,437    
Issuance of common stock upon the vesting of restricted stock units (in shares)   336,939      
Other comprehensive income (loss) (94)     (94)  
Ending balance (in shares) at Mar. 31, 2025   41,995,537      
Ending balance at Mar. 31, 2025 $ 342,458 $ 6 727,697 85 (385,330)
Beginning balance (in shares) at Dec. 31, 2024 38,349,826 38,349,826      
Beginning balance at Dec. 31, 2024 $ 224,534 $ 6 584,559 179 (360,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (45,460)        
Exercise of vested stock options (in shares) 135,231        
Ending balance (in shares) at Jun. 30, 2025 42,210,972 42,210,972      
Ending balance at Jun. 30, 2025 $ 332,612 $ 6 738,237 39 (405,670)
Beginning balance (in shares) at Mar. 31, 2025   41,995,537      
Beginning balance at Mar. 31, 2025 342,458 $ 6 727,697 85 (385,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (20,340)       (20,340)
Recognition of stock-based compensation expense 8,234   8,234    
Exercise of vested stock options (in shares)   56,795      
Exercise of vested stock options 1,205   1,205    
Issuance of common stock upon the vesting of restricted stock units (in shares)   126,639      
Shares issued in connection with the employee stock purchase plan (in shares)   32,001      
Shares issued in connection with the employee stock purchase plan 1,101   1,101    
Other comprehensive income (loss) $ (46)     (46)  
Ending balance (in shares) at Jun. 30, 2025 42,210,972 42,210,972      
Ending balance at Jun. 30, 2025 $ 332,612 $ 6 $ 738,237 $ 39 $ (405,670)